other material
confidence high
sentiment negative
materiality 0.65
ClearPoint Neuro enters $50M ATM equity offering with Stifel
ClearPoint Neuro, Inc.
- ATM agreement with Stifel allows sale of up to $50M in common stock from time to time.
- Agent commission of 3.0% of gross sales proceeds; shares sold via Nasdaq Capital Market.
- Prospectus supplement filed Nov 7, 2024; registration statement effective since Nov 20, 2023.
- Company not obligated to sell any shares; may suspend or terminate offering at any time.